The trademark application CARNISAL was filed by Aspire Pharma Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on September 15, 2024, and still open for oppositions.
The application was filed in English (French was selected as the second language).